SUAVURET 0.15 mg/0.02 mg TABLETS

Introduction

Package Leaflet: Information for the User

Suavuret 0.15 mg/0.02 mg tablets

desogestrel/ethinylestradiol

Important things to know about combined hormonal contraceptives (CHCs):

• They are one of the most reliable reversible contraceptive methods if used correctly.
• They slightly increase the risk of having a blood clot in the veins and arteries, especially in the first year or when restarting a combined hormonal contraceptive after a break of 4 weeks or more.
• Be alert and consult your doctor if you think you may have symptoms of a blood clot (see section 2 "Blood clots").

Read the entire package leaflet carefully before starting to take this medication, as it contains important information for you.

• Keep this package leaflet, as you may need to read it again.
• If you have any questions, consult your doctor or pharmacist.
• This medication has been prescribed to you only, and you should not give it to others, even if they have the same symptoms as you, as it may harm them.
• If you experience side effects, consult your doctor or pharmacist, even if they are side effects not listed in this package leaflet. See section 4.

Contents of the package leaflet

1. What Suavuret tablets are and what they are used for
2. What you need to know before you start taking Suavuret tablets
3. How to take Suavuret tablets
4. Possible side effects
5. Storage of Suavuret tablets
6. Package contents and additional information

1. What Suavuret tablets are and what they are used for

Suavuret belongs to the group of medications called oral monophasic contraceptives ("The Pill" combined). All the tablets in the package contain the same combination of active ingredients.

Suavuret is indicated to prevent pregnancy.

2. What you need to know before you start taking Suavuret tablets

General considerations

Before you start using Suavuret, you should read the information about blood clots in section 2. It is particularly important that you read the symptoms of a blood clot (see section 2 "Blood clots").

Do not take Suavuret

You should not use Suavuret if you have any of the conditions listed below. Inform your doctor if you have any of the conditions listed below. Your doctor will discuss with you what other form of contraception would be more suitable. See also the section "When you should be careful with Suavuret".

• If you have (or have ever had) a blood clot in a blood vessel of the legs (deep vein thrombosis, DVT), in the lungs (pulmonary embolism, PE) or in other organs.
• If you know you have a disorder that affects blood clotting: for example, protein C deficiency, protein S deficiency, antithrombin III deficiency, factor V Leiden or antiphospholipid antibodies.
• If you need an operation or if you spend a lot of time without getting up (see section "Blood clots").
• If you have ever had a heart attack or a stroke.
• If you have (or have ever had) angina pectoris (a condition that causes severe chest pain and may be the first sign of a heart attack) or a transient ischemic attack (TIA, temporary symptoms of a stroke).
• If you have any of the following diseases that can increase your risk of forming a clot in the arteries:

• Severe diabetes with blood vessel damage.
• Very high blood pressure.
• Very high levels of fat in the blood (cholesterol or triglycerides).
• A condition called hyperhomocysteinemia.
• • If you have (or have ever had) a type of migraine called "migraine with aura".
  • If you have or have had inflammation of the pancreas (pancreatitis), along with high levels of fat in your blood.
  • If you have jaundice (yellowish color of the skin) or severe liver disease.
  • If you have or have ever had a cancer that grows influenced by sex hormones (e.g. breast or genital organs).
  • If you have or have ever had a tumor in the liver.
  • If there is any unexplained vaginal bleeding.
  • If you have abnormal growth of the inner tissue of the uterus.
  • If you are pregnant or think you may be pregnant.
  • If you are allergic to desogestrel or ethinylestradiol or any of the other components of this medicine (listed in section 6).
  • If you have hepatitis C and are taking medications that contain ombitasvir/paritaprevir/ritonavir and dasabuvir or glecaprevir/pibrentasvir (see also the section "Taking Suavuret with other medicines").

If any of these circumstances occur for the first time while using the pill, do not take any more and consult your doctor immediately. In the meantime, use non-hormonal contraceptive measures.

Warnings and precautions

When you should be careful with Suavuret

Before starting treatment with Suavuret

Tell your doctor if you suffer from any of the following conditions.

If the condition develops or worsens while you are using Suavuret, you should also inform your doctor.

• If you are a smoker.
• If you are diabetic.
• If you are overweight.
• If you have high blood pressure.
• If you have heart rhythm disorders or certain heart conditions.
• If you have inflammation of the veins that are under the skin (superficial thrombophlebitis).
• If you have varicose veins.
• If any of your close relatives have had thrombosis, heart attack or cerebral embolism.
• If you have migraines.
• If you suffer from epilepsy.
• If you have high levels of fat in the blood (hypertriglyceridemia) or a known family history of this condition. Hypertriglyceridemia has been associated with a higher risk of developing pancreatitis (inflammation of the pancreas).
• If you need an operation or spend a lot of time without getting up (see section 2 "Blood clots").
• If you have just given birth, you are at a higher risk of suffering from blood clots. You should ask your doctor when you can start taking Suavuret after childbirth.
• If any of your close relatives have had breast cancer.
• If you have liver or gallbladder disease.
• If you have Crohn's disease or ulcerative colitis (chronic inflammatory bowel disease).
• If you have systemic lupus erythematosus (SLE, a disease that affects your natural defense system).
• If you have hemolytic uremic syndrome (HUS, a blood clotting disorder that causes kidney failure).
• If you have sickle cell anemia (a hereditary disease of red blood cells).
• If you have a disease that appeared or worsened during pregnancy or previous use of sex hormones (e.g. hearing loss, a metabolic disease called porphyria, a skin disease called gestational herpes or a disease called Sydenham's chorea).
• If you experience symptoms of angioedema, such as swelling of the face, tongue and/or throat, and/or difficulty swallowing, or urticaria possibly with difficulty breathing, contact your doctor immediately. Medications that contain estrogens can cause or worsen the symptoms of hereditary and acquired angioedema.
• If you have or have had chloasma (yellowish-brown spots on the skin, particularly on the face); in this case, you should avoid very intense sun exposure or ultraviolet radiation.

In the event that any of the above situations appear for the first time, have a relapse or worsen with treatment with the pill, you should consult your doctor, who may recommend that you stop taking the pill.

Suavuret, like all contraceptive pills, does not protect against AIDS or any other sexually transmitted disease.

Once you have started treatment with Suavuret

While you are taking the pill, your doctor will require you to undergo periodic check-ups, usually once a year.

Contact your doctor as soon as possible in the following cases:

• If you notice possible signs of a blood clot that may mean you are suffering from a blood clot in the leg (i.e. deep vein thrombosis), a blood clot in the lung (i.e. pulmonary embolism), a heart attack or a stroke (see section "Blood clots" below).

To get a description of the symptoms of these serious side effects, see "How to recognize a blood clot".

BLOOD CLOTS

The use of a combined hormonal contraceptive like Suavuret increases your risk of suffering from a blood clot compared to not using it. In rare cases, a blood clot can block blood vessels and cause serious problems.

Blood clots can form:

• In the veins (which is called "venous thrombosis", "venous thromboembolism" or VTE).
• In the arteries (which is called "arterial thrombosis", "arterial thromboembolism" or ATE).

Recovery from blood clots is not always complete. In rare cases, there can be serious lasting effects or, very rarely, they can be fatal.

It is important to remember that the overall risk of a harmful blood clot due to Suavuret is small.

HOW TO RECOGNIZE A BLOOD CLOT

Seek urgent medical attention if you notice any of the following signs or symptoms.

BLOOD CLOTS IN A VEIN

What can happen if a blood clot forms in a vein?

• The use of combined hormonal contraceptives has been associated with an increased risk of blood clots in the veins (venous thrombosis). However, these side effects are rare. They occur more frequently in the first year of use of a combined hormonal contraceptive.
• If a blood clot forms in a vein of the leg or foot, it can cause deep vein thrombosis (DVT).
• If a blood clot moves from the leg and becomes lodged in the lung, it can cause a pulmonary embolism.
• In very rare cases, a clot can form in a vein of another organ such as the eye (retinal vein thrombosis).

When is the risk of a blood clot in a vein higher?

The risk of a blood clot in a vein is higher during the first year in which you take a combined hormonal contraceptive for the first time. The risk may also be higher if you start taking a combined hormonal contraceptive (the same medicine or a different one) after an interruption of 4 weeks or more.

After the first year, the risk decreases, but it is always slightly higher than if you were not taking a combined hormonal contraceptive.

When you stop taking Suavuret, your risk of a blood clot returns to normal within a few weeks.

What is the risk of a blood clot?

The risk depends on your natural risk of VTE and the type of combined hormonal contraceptive you are taking.

The overall risk of a blood clot in the leg or lung (DVT or PE) with Suavuret is small.

• Out of 10,000 women who do not use a combined hormonal contraceptive and are not pregnant, about 2 will have a blood clot in a year.

• Out of 10,000 women who use a combined hormonal contraceptive that contains levonorgestrel or norethisterone or norgestimate, about 5-7 will have a blood clot in a year.

• Out of 10,000 women who use a combined hormonal contraceptive that contains desogestrel like Suavuret, between 9 and 12 women will have a blood clot in a year.

• The risk of a blood clot will depend on your personal history (see "Factors that increase your risk of a blood clot" below).

Factors that increase your risk of a blood clot in a vein

The risk of a blood clot with Suavuret is small, but some conditions increase the risk. Your risk is higher:

• If you are overweight (body mass index or BMI over 30 kg/m2).
• If any of your close relatives have had a blood clot in the leg, lung or other organ at a young age (i.e. before the age of 50). In this case, you may have a hereditary disorder of blood clotting.
• If you need an operation or spend a lot of time without getting up due to an injury or illness or if you have your leg in a cast. You may need to stop using Suavuret several weeks before the operation or while you have less mobility. If you need to stop using Suavuret, ask your doctor when you can start using it again.
• As you get older (especially over 35 years).
• If you have given birth recently.

The risk of a blood clot increases the more conditions you have.

Long-distance flights (more than 4 hours) can temporarily increase the risk of a blood clot, especially if you have any of the other risk factors listed.

It is important to inform your doctor if you suffer from any of the above conditions, even if you are not sure. Your doctor may decide that you should stop using Suavuret.

If any of the above conditions change while you are using Suavuret, for example, a close relative experiences a thrombosis without a known cause or you gain a lot of weight, inform your doctor.

BLOOD CLOTS IN AN ARTERY

What can happen if a blood clot forms in an artery?

Like a blood clot in a vein, a clot in an artery can cause serious problems. For example, it can cause a heart attack or a stroke.

Factors that increase your risk of a blood clot in an artery

It is important to note that the risk of a heart attack or stroke due to Suavuret is very small, but it can increase:

• With age (over 35 years).
• If you smoke.When you use a combined hormonal contraceptive like Suavuret, you are advised to stop smoking. If you are not able to stop smoking and are over 35 years old, your doctor may advise you to use a different type of contraceptive.
• If you are overweight.
• If you have high blood pressure.
• If any of your close relatives have had a heart attack or stroke at a young age (less than 50 years). In this case, you may also be at higher risk of having a heart attack or stroke.
• If you or any of your close relatives have a high level of fat in the blood (cholesterol or triglycerides).
• If you have migraines, especially migraines with aura.
• If you have a heart problem (valve disorders, heart rhythm disorder called atrial fibrillation).
• If you have diabetes.

If you have one or more of these conditions or if any of them are particularly severe, the risk of a blood clot may be increased even further.

If any of the above conditions change while you are using Suavuret, for example, you start smoking, a close relative experiences a thrombosis without a known cause or you gain a lot of weight, inform your doctor.

Blood pressure

If you have hypertension (high blood pressure) or a disease related to hypertension (including certain kidney diseases), it is preferable to use other contraceptive methods. If you decide to use Suavuret, you should be closely monitored by your doctor.

3. How to take Suavuret tablets

Follow the administration instructions of this medication indicated by your doctor exactly. In case of doubt, consult your doctor or pharmacist again.

The Suavuret blister pack has 21 tablets marked with the days of the week. Take your tablet approximately at the same time every day, with liquid if necessary.

Each time you start a new Suavuret blister pack, take the tablet from the top row that corresponds to the day of the week you take it.

Follow the direction of the arrows until you finish the 21 tablets.

In the following 7 days, you should not take Suavuret, during which a withdrawal bleed (deprivation bleeding) will appear, which usually starts two or three days after the last Suavuret tablet. Continue with the next blister pack on the eighth day, even if you still have your period. This way, you will always start the blister packs on the same day of the week and will have the withdrawal bleeding approximately on the same days each month.

Use in children and adolescents

There are no clinical data available on safety and efficacy in adolescents under 18 years of age.

The first Suavuret blister pack

If you have not used hormonal contraception in the previous month.

Start taking Suavuret on the first day of your cycle, i.e., the first day of menstruation. Suavuret will start working immediately. You do not need to take additional contraceptive measures. You can also start on days 2 to 5 of your cycle, but in this case, make sure to use a complementary contraceptive method (e.g., a barrier method) while taking the first 7 tablets of the first cycle. Do not use methods based on the menstrual cycle or temperature, as these methods are not reliable while taking the pill.

Switching from another hormonal contraceptive (combined contraceptive pill, vaginal ring, or transdermal patch).

You can start taking Suavuret the day after taking the last tablet of the current blister pack. This means you do not need to leave a rest period. If your current preparation has inactive tablets, you can start Suavuret the day after the last activetablet (if you are unsure, consult your doctor or pharmacist). You can also start later, but never after the rest period of your current preparation (or after the last inactive tablet of your current preparation). In the case of using a vaginal ring or transdermal patch, you should start taking Suavuret preferably on the same day of ring removal or on the day the patch should be removed. You can also start, but no later than the day the next patch or ring application is due.

If you have taken the pill or used the vaginal ring or patch continuously and correctly and are sure you are not pregnant, you can also stop taking the pill or remove the vaginal ring or patch any day of your current cycle and start with Suavuret immediately.

If you follow these instructions, you do not need to use an additional contraceptive method.

Switching from a progestin-only pill.

You can stop taking your current pill any day and start taking Suavuret the next day at the same time, but make sure to use a complementary contraceptive method (e.g., a barrier method) while taking the first 7 tablets if you have sexual intercourse.

Switching from an injectable, implant, or Intrauterine System (IUS) with progestin only.

Start using Suavuret when you should receive the next injection or on the day the implant or IUS is removed, but make sure to use a complementary contraceptive method (barrier method) while taking the first 7 tablets if you have sexual intercourse.

After childbirth.

If you have just had a child, your doctor may advise you to wait until your first normal period appears before starting Suavuret. Sometimes it is possible to start earlier, but your doctor will advise you on how to do so. If you are breastfeeding and want to use Suavuret, you should discuss it with your doctor first.

After an abortion.

Consult your doctor.

You can stop taking Suavuret at any time. If you stop Suavuret because you want to become pregnant, it is generally recommended to wait until you have had your first natural period before trying to conceive, which will help you calculate the due date.

If you take more Suavuret than you should

In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone: 91 562 04 20, indicating the medication and the amount ingested.

No serious effects have been reported due to taking an excess of Suavuret tablets at one time. If you have taken several tablets at once, you may experience nausea, vomiting, or vaginal bleeding.

If you forget to take Suavuret

If less than 12 hourshave passed since the usual time, the reliability of the pill is maintained. Take the tablet as soon as you remember and continue taking the following tablets at the usual time.

If more than 12 hourshave passed since the usual time, the reliability of the pill may be reduced. The more consecutive tablets you have forgotten, the higher the risk that the contraceptive efficacy will decrease. The risk of becoming pregnant is particularly higher if you forget tablets at the beginning or end of the blister pack. Therefore, you should follow the recommendations outlined below (see also the diagram).

If you forget more than one tablet in a pack

Consult your doctor.

If you forget 1 tablet in the first week

Take the forgotten tablet as soon as you remember (even if it means taking two tablets at once) and take the following tablets at the usual time. Take complementary contraceptive precautions (barrier method) for the next 7 days.

If you have had sexual intercourse in the previous week, there is a possibility that you may have become pregnant. Therefore, inform your doctor immediately.

If you forget 1 tablet in the second week

Take the forgotten tablet as soon as you remember (even if it means taking two tablets at once) and take the following tablets at the usual time. The reliability of the pill is maintained, and you do not need to take complementary contraceptive precautions.

If you forget 1 tablet in the third week

You can choose either of the following options, without needing to take complementary contraceptive precautions.

1- Take the forgotten tablet as soon as you remember (even if it means taking two tablets at once) and take the following tablets at the usual time. Start the next blister pack the day after finishing the current pack without leaving a rest period between packs. You may not have your period until the end of the second pack, although you may experience spotting or a small period while taking the tablets from the second pack.

Or,

2- Stop taking the tablets from the current pack, leave a rest period of up to 7 days (including the day you forgot the tablet), and continue with the next pack. Following this method, you can always start your next pack on the same day of the week you usually do.

If you have forgotten tablets in a pack and do not have your expected period during the first normal rest period, you may be pregnant.

Consult your doctor before starting the next pack.

If you vomit or have severe diarrhea

If you vomit or have severe diarrhea within 3 or 4 hours after taking your Suavuret tablet, it may be that the active ingredients are not fully absorbed, which is equivalent to forgetting a tablet. Therefore, follow the recommendations for a forgotten tablet.

In the case of severe diarrhea, consult your doctor.

If you want to change the day your period starts

If you take the tablets as indicated, you will have your period approximately on the same day every 4 weeks. If you want to change it, you should shorten (never lengthen) the next rest period. For example, if your period usually starts on Friday and you want it to start on Tuesday in the future, i.e., three days earlier, you should start the next pack three days earlier than the day you usually start. If the rest period is very short, 1 to 3 days, you may not have bleeding during the rest period and may experience spotting during the next pack.

If you have unexpected bleeding

As with all pills, irregular vaginal bleeding or spotting between periods may occur during the first months (called intermenstrual bleeding or spotting). In this case, continue taking the tablets normally. This irregular vaginal bleeding usually disappears once your body has adapted to the pill, usually after three cycles.

If it continues, becomes more intense, or reappears, consult your doctor.

If your period does not appear

If you have taken all the tablets at the same time and have not vomited, had severe diarrhea, or taken other medications, it is very unlikely that you are pregnant. Continue taking Suavuret as usual.

If you have two consecutive failures, you may be pregnant, so you should inform your doctor immediately. Do not start the next Suavuret pack until your doctor has confirmed that you are not pregnant.

4. Possible Adverse Effects

Like all medicines, this medicine can cause adverse effects, although not all people suffer from them. If you experience any adverse effect, especially if it is severe and persistent, or have any change in health that you think may be due to Suavuret, consult your doctor.

All women who take combined hormonal contraceptives are at a higher risk of developing blood clots in the veins (venous thromboembolism (VTE)) or blood clots in the arteries (arterial thromboembolism (ATE)). For more detailed information on the different risks of taking combined hormonal contraceptives, see section 2 "What you need to know before you start using Suavuret".

Contact your doctor immediately if you experience any of the following symptoms of angioedema: swelling of the face, tongue and/or throat, and/or difficulty swallowing, or hives possibly with difficulty breathing (see also section 2 "What you need to know before you start taking Suavuret tablets").

Adverse effects are listed below, classified according to their frequency, based on the following criteria:

Frequent: (may affect up to 1 in 10 people).

Uncommon: (may affect up to 1 in 100 people).

Rare: (may affect up to 1 in 1,000 people).

Frequent (may affect up to 1 in 10 people):

• depressive mood, mood changes
• headache
• nausea, abdominal pain
• breast pain, breast tenderness
• weight gain

Uncommon (may affect up to 1 in 100 people):

• fluid retention
• decreased sexual desire
• migraines
• vomiting, diarrhea
• skin rash, hives
• breast enlargement

Rare (may affect up to 1 in 1,000 people):

• harmful blood clots in a vein or artery, for example:

• in a leg or foot (i.e., DVT),
• in a lung (i.e., PE),
• heart attack,
• stroke,
• mild stroke or temporary symptoms similar to those of a stroke, known as a transient ischemic attack (TIA),
• blood clots in the liver, stomach/intestine, kidneys, or eye.

The risk of having a blood clot may be higher if you have any other condition that increases this risk (see section 2 for more information on conditions that increase the risk of blood clots and symptoms of a blood clot).

• allergic reactions
• increased sexual desire
• intolerance to contact lenses
• erythema nodosum, erythema multiforme (which are skin diseases)
• altered menstrual flow, breast secretion
• weight loss

Reporting of Adverse Effects:

If you experience any type of adverse effect, consult your doctor or pharmacist, even if it is a possible adverse effect that is not listed in this leaflet. You can also report them directly through the Spanish Pharmacovigilance System for Human Use Medicines: https://www.notificaram.es. By reporting adverse effects, you can contribute to providing more information on the safety of this medicine.

5. Storage of Suavuret Tablets

Keep this medicine out of the sight and reach of children.

Do not store above 30 °C.

Store in the original packaging.

Do not use this medicine after the expiration date that appears on the packaging after the abbreviation CAD. The expiration date is the last day of the month indicated.

Do not use this medicine if you observe, for example, a change in color, broken tablets, or any other visible sign of deterioration.

Medicines should not be disposed of through wastewater or household waste. Deposit the packaging and medicines you no longer need at the pharmacy's SIGRE point. In case of doubt, ask your pharmacist how to dispose of the packaging and medicines you no longer need. This will help protect the environment.

6. Package Contents and Additional Information

Suavuret Composition

• The active ingredients are: desogestrel and ethinylestradiol. One tablet contains 0.15 mg of desogestrel and 0.02 mg of ethinylestradiol.

• The other ingredients are: anhydrous colloidal silica, all-rac-alpha-tocopherol, lactose monohydrate, potato starch, povidone, and stearic acid.

Product Appearance and Package Contents

The tablets are white, biconvex, round, and 6 mm in diameter. Each tablet has a marked code, TR on 4 on one side and Organon and an asterisk on the opposite side.

Suavuret is presented in aluminum/PVC blisters of 21 tablets, packaged in a sealed aluminum laminate pouch. The pouches are packaged in boxes with 1x21 and 3x21 tablets.

Marketing Authorization Holder and Manufacturer

Marketing Authorization Holder:

Organon Salud, S.L.

Paseo de la Castellana, 77

28046 Madrid

Spain

Tel.: 915911279

Manufacturer:

N.V. Organon

Kloosterstraat 6,

5349 AB, Oss,

Netherlands

Date of the Last Revision of this Leaflet:September 2022.

Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/